Condition
Extrapulmonary Small Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Extrapulmonary Small Cell Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), United States (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Autologous B7-H3 CAR T Cells in Advanced Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer
This study tests a patient’s own B7-H3 CAR T cells to see if they can help people 18 and older whose small cell lung cancer or EPNEC has come back or hasn’t responded to prior treatment.
-
Treatment for extensive stage extrapulmonary small cell carcinoma using durvalumab with chemotherapy
This study is testing if a new combination of durvalumab with chemotherapy can help people with advanced extrapulmonary small cell carcinoma feel better and live longer.
Related topics
Quick answers
How many Extrapulmonary Small Cell Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.